Three deliberate steps. Six brokers compared (Zerodha, ICICI Direct, HDFC Sec, Kotak, Axis, ProStocks) on NRI eligibility, FATCA acceptance, cost and onboarding speed. PIS vs Non-PIS routing — what to fund from where. Six AMCs ranked, with the PFIC trap for US-NRIs explained — the part most "NRI investing" content silently skips.
What we ignore: NFO marketing pitches, sector/themed funds promising "this cycle's winner", regular plans with embedded distributor fees, "smart-beta" gimmicks that closet-index Nifty.
0 paid placements ever. Quarterly editorial audit · last full review: May 2026.
Picks change quarterly when we audit live AMC US-NRI policies + reader feedback. No broker pays us. No AMC pays us.
NFOs (New Fund Offers): AMCs push these because the fund houses earn marketing commissions. There's no track record. Wait 18 months and look at actual performance.
Themed/sector funds (banking, IT, pharma): the marketing pitch is timing the cycle. In practice you'll buy at the top and sell at the bottom. Skip.
Regular plans (vs Direct plans): 0.5–1% extra fee for "advice" you'll never use. If your distributor pushed regular plans, switch.
Detailed answers on our Q&A page.